Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neopath (NPTH) -- Ignore unavailable to you. Want to Upgrade?

To: Real_Gator who wrote (158)	7/23/1998 11:44:00 PM
From: John Zwiener	Respond to of 178

I still have my small toehold in this company. I've lately been totally diverted by Igen and Sepracor over the past year, as well as a few others that have been coming into their own recently. But now does seem to be the time to relook at NPTH since the have gotten conditional approval as a primary reader and have doubled their revenues from last year, and up 25% from last quarter. It will probably take me a quarter or two to form a new impressionand see if they are forming an inflection point some time in the future. I'm glad you asked about this company since it is moving forward and is worth checking on again to see if has real potential.